All lobbying filings

ALSTON & BIRD LLP

ALSTON & BIRD LLP filed a Q3 report for VERTEX PHARMACEUTICALS INCORPORATED on October 20, 2026, reporting $50,000 in lobbying income.

Lobbying for VERTEX PHARMACEUTICALS INCORPORATED · Pharmaceutical Manufacturer

All filings by ALSTON & BIRD LLP · Everything VERTEX PHARMACEUTICALS INCORPORATED has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Budget/Appropriations

FY2027 Appropriations bills.

Health Issues

FY2027 Appropriations bills.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.